Home
Conditions
Burkitt Lymphoma

Clinical trial condition

Burkitt Lymphoma

Explore clinical trials studying Burkitt Lymphoma. Study availability and eligibility vary by location and protocol.

695 public trials 115 recruiting studies

Refine in advanced search Browse all conditions

Burkitt Lymphoma trial results

Completed

Iodine I 131 Tositumomab, Etoposide and Cyclophosphamide Followed by Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

NCT00073918

Conditions: Anaplastic Large Cell Lymphoma, Blood Protein Disorders, Burkitt Lymphoma, +50 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Fenretinide in Treating Patients With Refractory or Relapsed Hematologic Cancer

NCT00104923

Conditions: Blood Coagulation Disorders, Blood Platelet Disorders, Blood Protein Disorders, +58 more
Locations: USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States

Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States

M. D. Anderson Cancer Center at University of Texas Houston, Texas, United States

Joe Arrington Cancer Research and Treatment Center Lubbock, Texas, United States

View Trial Details

Completed

Allogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based Regimen

NCT00448357

Conditions: Blast Crisis, Blood Coagulation Disorders, Blood Platelet Disorders, +72 more
Locations: Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States

View Trial Details

Completed

A Safety Study of SGN-CD19A for Leukemia and Lymphoma

NCT01786096

Conditions: Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +19 more
Locations: Children's Hospital of Alabama / University of Alabama at Birmingham Birmingham, Alabama, United States

University of Alabama at Birmingham Birmingham, Alabama, United States

Mayo Clinic Arizona Scottsdale, Arizona, United States

City of Hope National Medical Center Duarte, California, United States

View all 13 locations

View Trial Details

Completed

Experimental Vaccine for Malaria in Adults in Mali

NCT00343005

Conditions: Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +21 more
Locations: Malaria Research and Training Center (MRTC) Bamako, Mali

View Trial Details

Completed

Malaria Vaccine in Children in Mali

NCT00341250

Conditions: Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +19 more
Locations: Bancoumana Clinical Trial Center Bankoumana, Mali

Doneguebougou Malaria Vaccine Center Donéguébougou, Mali

View Trial Details

Completed

Phase I Study of Safety and Immunogenicity of AMA1-C1Alhydrogel + CPG 7909 Vaccine for Malaria

NCT00414336

Conditions: Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +19 more
Locations: Doneguebougou Malaria Vaccine Center Donéguébougou, Mali

View Trial Details

Completed

Gemcitabine Hydrochloride, Carboplatin, Dexamethasone, and Rituximab in Treating Patients With Previously Treated Lymphoid Malignancies

NCT00072514

Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +80 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplant

NCT00691015

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Burkitt Lymphoma, +57 more
Locations: Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States

View Trial Details

Completed

Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease

NCT00448201

Conditions: Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +66 more
Locations: Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States

View Trial Details

Burkitt Lymphoma

Burkitt Lymphoma trial results

Related conditions